BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hullegie SJ, Arends JE, Rijnders BJ, Irving WL, Salmon D, Prins M, Wensing AM, Klenerman P, Leblebicioglu H, Boesecke C, Rockstroh JK, Hoepelman AI. Current knowledge and future perspectives on acute hepatitis C infection. Clin Microbiol Infect 2015;21:797.e9-797.e17. [PMID: 25892133 DOI: 10.1016/j.cmi.2015.03.026] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Rockstroh JK, Boesecke C. Hepatitis C Virus Treatment as Prevention: Challenges and Opportunities in Men Who Have Sex With Men. J Infect Dis 2020;222:S782-8. [PMID: 33245348 DOI: 10.1093/infdis/jiaa096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yeh YJ, Tseng CP, Hsu SD, Huang HY, Lai MMC, Huang HD, Cheng JC. Dual Effects of Let-7b in the Early Stage of Hepatitis C Virus Infection. J Virol 2021;95:e01800-20. [PMID: 33208444 DOI: 10.1128/JVI.01800-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Wiessing L, Giraudon I, Duffell E, Veldhuijzen I, Zimmermann R, Hope V. Epidemiology of Hepatitis C Virus: People Who Inject Drugs and Other Key Populations. Hepatitis C: Epidemiology, Prevention and Elimination 2021. [DOI: 10.1007/978-3-030-64649-3_6] [Reference Citation Analysis]
4 Liu Y, Zhang H, Zhang L, Zou X, Ling L. Economic Evaluation of Hepatitis C Treatment Extension to Acute Infection and Early-Stage Fibrosis Among Patients Who Inject Drugs in Developing Countries: A Case of China. Int J Environ Res Public Health 2020;17:E800. [PMID: 32012839 DOI: 10.3390/ijerph17030800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Rockstroh J, Boesecke C. Treatment of acute hepatitis C in HIV coinfection: Is this a chance for achieving microelimination?United European Gastroenterol J. 2019;7:465-466. [PMID: 31065363 DOI: 10.1177/2050640619843735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 Tolentino B, Singh RR, Misra S, Dieterich DT, Sarpel D. An update on the management of hepatitis C virus and human immunodeficiency virus co-infection. Future Virology 2019;14:185-195. [DOI: 10.2217/fvl-2018-0116] [Reference Citation Analysis]
7 Nguyen DB, Bixler D, Patel PR. Transmission of hepatitis C virus in the dialysis setting and strategies for its prevention. Semin Dial 2019;32:127-34. [PMID: 30569604 DOI: 10.1111/sdi.12761] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
8 Takamizawa S, Yamada T, Kitamura K, Hiraoka E. Difficulty of acute hepatitis C diagnosis in a hospitalised patient. BMJ Case Rep 2018;11:e226907. [PMID: 30567115 DOI: 10.1136/bcr-2018-226907] [Reference Citation Analysis]
9 Misra S, Dieterich DT, Saberi B, Kushner T. Direct-acting antiviral treatment of acute hepatitis C virus infections. Expert Rev Anti Infect Ther 2018;16:599-610. [PMID: 30067402 DOI: 10.1080/14787210.2018.1505502] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
10 Costagliola D, May M. Survival in individuals living with HIV. Curr Opin HIV AIDS 2016;11:451-4. [PMID: 27716729 DOI: 10.1097/COH.0000000000000304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
11 Rockstroh JK. [HCV healing also in HIV infected patients]. MMW Fortschr Med 2017;159:56-60. [PMID: 28597261 DOI: 10.1007/s15006-017-9739-6] [Reference Citation Analysis]
12 Brancaccio G, Sorbo MC, Frigeri F, Rizzo V, Cantone M, Genderini F, Fabeni L, Pinto A, Perno CF, Ceccherini-Silberstein F, Gaeta GB. Treatment of Acute Hepatitis C With Ledipasvir and Sofosbuvir in Patients With Hematological Malignancies Allows Early Re-start of Chemotherapy. Clin Gastroenterol Hepatol 2018;16:977-8. [PMID: 29104131 DOI: 10.1016/j.cgh.2017.10.032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
13 Bethea ED, Chen Q, Hur C, Chung RT, Chhatwal J. Reply. Hepatology 2018;67:1641-2. [PMID: 29315738 DOI: 10.1002/hep.29770] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Bethea ED, Chen Q, Hur C, Chung RT, Chhatwal J. Should we treat acute hepatitis C? A decision and cost-effectiveness analysis. Hepatology 2018;67:837-46. [PMID: 29059461 DOI: 10.1002/hep.29611] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
15 Hovaida M, Torrazza-Perez E, McCarthy D. Liver Function Tests "Gone Viral": Acute Hepatitis of Uncertain Cause. Dig Dis Sci 2018;63:32-5. [PMID: 29192376 DOI: 10.1007/s10620-017-4849-7] [Reference Citation Analysis]
16 Hullegie SJ, GeurtsvanKessel CH, van der Eijk AA, Ramakers C, Rijnders BJA. HCV antigen instead of RNA testing to diagnose acute HCV in patients treated in the Dutch Acute HCV in HIV Study. J Int AIDS Soc 2017;20:21621. [PMID: 28692208 DOI: 10.7448/IAS.20.1.21621] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
17 Klein MB, Rockstroh JK, Wittkop L. Effect of coinfection with hepatitis C virus on survival of individuals with HIV-1 infection. Curr Opin HIV AIDS. 2016;11:521-526. [PMID: 27716732 DOI: 10.1097/coh.0000000000000292] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
18 Hullegie SJ, Arends JEA, Groothuismink ZMA, Pas SD, Rijnders BJA, Boonstra A, Claassen MAA. Decreased pro-inflammatory immune responses during recurrent acute HCV infections in HIV co-infected patients. J Gen Virol 2017;98:1294-8. [PMID: 28597817 DOI: 10.1099/jgv.0.000768] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Am E. Seroprevalence of Hepatitis C Virus among Population in Luxor Governorate, Egypt. JHVRV 2017;5. [DOI: 10.15406/jhvrv.2017.05.00144] [Reference Citation Analysis]
20 Dirchwolf M, Marciano S, Mauro E, Ruf AE, Rezzonico L, Anders M, Chiodi D, Petta NG, Borzi S, Tanno F, Ridruejo E, Barreyro F, Shulman C, Plaza P, Carbonetti R, Tadey L, Schroder T, Fainboim H. Clinical epidemiology of acute hepatitis C in South America. J Med Virol 2017;89:276-83. [PMID: 27253181 DOI: 10.1002/jmv.24588] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
21 Spaan M, Hullegie SJ, Beudeker BJ, Kreefft K, van Oord GW, Groothuismink ZM, van Tilborg M, Rijnders B, de Knegt RJ, Claassen MA, Boonstra A. Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy. PLoS One. 2016;11:e0159243. [PMID: 27416100 DOI: 10.1371/journal.pone.0159243] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 6.7] [Reference Citation Analysis]
22 Leask JD, Dillon JF. Review article: treatment as prevention - targeting people who inject drugs as a pathway towards hepatitis C eradication. Aliment Pharmacol Ther 2016;44:145-56. [PMID: 27199103 DOI: 10.1111/apt.13673] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
23 Grammatikos G, Dietz J, Ferreiros N, Koch A, Dultz G, Bon D, Karakasiliotis I, Lutz T, Knecht G, Gute P, Herrmann E, Zeuzem S, Mavromara P, Sarrazin C, Pfeilschifter J. Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels. Int J Mol Sci 2016;17:E922. [PMID: 27304952 DOI: 10.3390/ijms17060922] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
24 Puri P, Saraswat VA, Dhiman RK, Anand AC, Acharya SK, Singh SP, Chawla YK, Amarapurkar DN, Kumar A, Arora A, Dixit VK, Koshy A, Sood A, Duseja A, Kapoor D, Madan K, Srivastava A, Kumar A, Wadhawan M, Goel A, Verma A, Shalimar, Pandey G, Malik R, Agrawal S. Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016. J Clin Exp Hepatol 2016;6:119-45. [PMID: 27493460 DOI: 10.1016/j.jceh.2016.07.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
25 Hullegie SJ, Claassen MA, van den Berk GE, van der Meer JT, Posthouwer D, Lauw FN, Leyten EM, Koopmans PP, Richter C, van Eeden A, Bierman WF, Newsum AM, Arends JE, Rijnders BJ. Boceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients. J Hepatol 2016;64:807-12. [PMID: 26689767 DOI: 10.1016/j.jhep.2015.12.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
26 Cloherty G, Talal A, Coller K, Steinhart C, Hackett J Jr, Dawson G, Rockstroh J, Feld J. Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection. J Clin Microbiol 2016;54:265-73. [PMID: 26659219 DOI: 10.1128/JCM.02407-15] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
27 Zhang B, Nguyen NH, Yee BE, Yip B, Ayoub WS, Lutchman GA, Nguyen MH. Treatment of Acute Hepatitis C Infection with Pegylated Interferon and Ribavirin in Patients Coinfected with Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis. Intervirology 2015;58:242-9. [PMID: 26402746 DOI: 10.1159/000437427] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]